G. Mann

A. Attarbaschi, T. Klingebiel, U. Pötschger, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group.

K. Horibe, A. Uyttebroeck, L. Brugières, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Natural course of a Wilms' tumour

I. Slavc, H. Gadner, G. Mann, 1999, The Lancet.

Mutations of JAK 2 in acute lymphoblastic leukaemias associated with Down ’ s syndrome

G. Wainreb, A. Green, A. Borkhardt, 2008 .

IDA-FLAG—An Effective Reinduction Therapy for Poor Prognosis AML of Childhood—Report of a Multicenter Phase II Trial

C. Hassan, U. Bode, G. Fleischhack, 2001 .

Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.

W. Klapper, H. Stein, D. Hasenclever, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Asparagine and aspartic acid concentrations in bone marrow versus peripheral blood during Berlin–Frankfurt–Münster-based induction therapy for childhood acute lymphoblastic leukemia

O. Haas, A. Attarbaschi, U. Pötschger, 2012, Leukemia & lymphoma.

Lethal Pulmonary Complications After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation

A. Attarbaschi, U. Pötschger, H. Gadner, 2012, The Pediatric infectious disease journal.

Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease.

B. Schneeweiss, P. Valent, I. Simonitsch, 2004, American journal of clinical pathology.

Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.

M. Schrappe, G. Henze, G. Escherich, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome

J. Tchinda, S. Raimondi, N. Heerema, 2014, Leukemia.

Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised contro

D. Hasenclever, K. Dieckmann, D. Vordermark, 2021, The Lancet. Oncology.

Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients

T. Lion, A. Attarbaschi, C. Peters, 2010, Leukemia.

Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia

M. König, O. Haas, A. Attarbaschi, 2016, Haematologica.

Clone-specific secondary aberrations are not detected in neonatal blood spots of children with ETV6-RUNX1-positive leukemia

O. Haas, R. Marschalek, M. Morak, 2013, Haematologica.

Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis.

D. Printz, H. Gadner, G. Mann, 1993, Blood.

Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis

D. Printz, H. Gadner, G. Mann, 1993 .

Detection of Residual Disease in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia by Comparative Phenotype Mapping: Method and Significance

H. Gadner, G. Mann, G. Fritsch, 2000, Leukemia & lymphoma.

Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.

C. Pui, R. Pieters, N. Heerema, 2014, Blood.

Treatment outcome of CRLF2 ‐rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP‐BFM and UK NCRI‐CCLG study groups

O. Haas, M. Schrappe, M. Morak, 2012, British journal of haematology.

Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin.

B. Nadel, O. Haas, O. Bodamer, 2007, Blood.

Role of the Erythropoietin Receptor in ETV6/RUNX1-Positive Acute Lymphoblastic Leukemia

M. Kauer, D. Beck, G. Mann, 2008, Clinical Cancer Research.

Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents

B. Burkhardt, A. Attarbaschi, A. Uyttebroeck, 2016, Haematologica.

Chronic myelomonocytic leukemia in childhood. A retrospective analysis of 110 cases.

J. Harbott, O. Haas, G. Basso, 1997 .

Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature

T. Lion, O. Haas, U. Pötschger, 2000, Bone Marrow Transplantation.

Extramedullary relapse despite graft-versus-leukemia effect after bone marrow transplantation in a girl with juvenile myelomonocytic leukemia.

M. König, O. Haas, H. Gadner, 1999, Leukemia & lymphoma.

Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood.

W. Friedrich, S. Burdach, A. Pession, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry.

W. Friedrich, G. Dini, S. Burdach, 1996, Bone marrow transplantation.

Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease

G. Mann, M. Minkov, S. Matthes-Martin, 2013, Annals of Hematology.

Recombinant human granulocyte-macrophage colony-stimulating factor in septic neutropenic pediatric cancer patients: detection of circulating hematopoietic precursor cells correlates with rapid granulocyte recovery.

H. Gadner, G. Mann, G. Fritsch, 1995, Medical and pediatric oncology.

childhood acute myeloblastic leukemia polymerase chain reaction screening in - Multiplex reverse transcriptase

M. König, O. Haas, G. Mann, 2011 .

Multiplex reverse transcriptase-polymerase chain reaction screening in childhood acute myeloblastic leukemia.

M. König, O. Haas, G. Mann, 2001, Blood.

High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.

G. Henze, T. Klingebiel, K. Schmiegelow, 2008, Blood.

Secondary Neoplasms Subsequent to Berlin-Frankfurt-Muenster (BFM) Therapy of Non-Hodgkin Lymphoma of Childhood: Significantly Higher Risk for Patients with Lymphoblastic Lymphoma Compared to Other NHL-Subtypes.

B. Burkhardt, M. Schrappe, R. Parwaresch, 2005 .

Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children

D. Reinhardt, H. Gadner, G. Mann, 2001, Annals of Hematology.

Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.

H. Kovar, D. Aryee, U. Pötschger, 1996, British Journal of Cancer.

Comment on HLH in a child with anaplastic large cell lymphoma (ALCL).

H. Gadner, G. Mann, 2008, Journal of pediatric hematology/oncology.

Pruritus in Pediatric Non-Hodgkin's Lymphoma

A. Attarbaschi, H. Gadner, A. Vécsei, 2002, Leukemia & lymphoma.

Lymphoblastic lymphoma and leukemia in children

A. Attarbaschi, H. Gadner, G. Mann, 2010 .

The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment‐related mortality and not an increased relapse rate – a population‐based analysis of 25 years of the Austrian ALL‐BFM (Berlin‐Frankfurt‐Münster) Study Group

O. Haas, B. Meister, A. Attarbaschi, 2013, British journal of haematology.

Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.

M. König, J. Harbott, O. Haas, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Copy Number Changes and Allele Distribution Patterns of Chromosome 21 in B Cell Precursor Acute Lymphoblastic Leukemia

M. König, O. Haas, A. Attarbaschi, 2021, Cancers.

Remission, treatment failure, and relapse in pediatric ALL: An international consensus of the Ponte-di-Legno Consortium.

M. Loh, C. Pui, S. Rives, 2021, Blood.

CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.

G. Basso, A. Attarbaschi, D. Printz, 2008, Blood.

Diagnosis and management of acute appendicitis in 21 pediatric hematology and oncology patients at a tertiary care cancer center

A. Attarbaschi, C. Hutter, G. Mann, 2021, Scientific reports.

Deletion of 11q23 is a highly specific nonrandom secondary genetic abnormality of ETV6/RUNX1-rearranged childhood acute lymphoblastic leukemia

T. Lion, M. König, O. Haas, 2007, Leukemia.

Near‐tetraploidy in childhood B‐cell precursor acute lymphoblastic leukemia is a highly specific feature of ETV6/RUNX1‐positive leukemic cases

M. König, O. Haas, A. Attarbaschi, 2006, Genes, chromosomes & cancer.

Abstract

K. Laczika, C. Marosi, D. Fuchs, 1984, Veterinary Record.

Key Treatment Questions in Childhood Acute Lymphoblastic Leukemia: Results in 5 Consecutive Trials Performed by the ALL-BFM Study Group From 1981 to 2000

J. Harbott, M. Schrappe, G. Henze, 2013, Klinische Pädiatrie.

Multiparameter phenotype mapping of normal and post-chemotherapy B lymphopoiesis in pediatric bone marrow

D. Printz, H. Gadner, G. Mann, 1997, Leukemia.

Flow‐cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B‐cell precursor acute lymphoblastic leukemia in trial AIEOP‐BFM‐ALL 2000

M. Schrappe, G. Basso, A. Attarbaschi, 2019, Pediatric blood & cancer.

directed immunotherapy leukemia during induction treatment: setting the stage for anti-CD20 CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic

G. Basso, D. Printz, H. Gadner, 2008 .

Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia—A population‐based analysis of the Austrian ALL‐BFM Study Group

O. Haas, A. Attarbaschi, U. Pötschger, 2022, EJHaem.

Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL.

A. Teigler‐Schlegel, O. Haas, M. Schrappe, 2017, Blood.

Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study.

M. Schrappe, M. Kuhlen, M. Valsecchi, 2019, European journal of cancer.

Detection of 1p36 deletions in paraffin sections of neuroblastoma tissues

P. Ambros, G. Amann, H. Gadner, 1993, Genes, chromosomes & cancer.

Treatment of Relapsed Acute Lymphoblastic Leukemia

H. Gadner, C. Peters, G. Mann, 2003 .

Histiocytosis following T-acute lymphoblastic leukemia: A BFM study

A. Attarbaschi, H. Gadner, G. Mann, 2005, Leukemia & lymphoma.

Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia

A. Attarbaschi, U. Pötschger, C. Peters, 2016, Annals of Hematology.

Outcome of Children and Adolescents With a Second or Third Relapse of Acute Lymphoblastic Leukemia (ALL): A Population-based Analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group

B. Meister, A. Attarbaschi, U. Pötschger, 2013, Journal of pediatric hematology/oncology.

Leucocyte transfusions from rhG‐CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients

T. Klingebiel, U. Pötschger, J. Starý, 1999, British journal of haematology.

Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma

U. Jaeger, P. Ambros, W. Knapp, 2002, Annals of Hematology.

Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study

M. Loh, C. Pui, A. Baruchel, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL.

O. Haas, M. Morak, A. Attarbaschi, 2012, Blood.

Thoracic Actinomycosis With Infiltration of the Spine: An Oncological Pitfall.

A. Attarbaschi, G. Amann, C. Hutter, 2017, Journal of pediatric hematology/oncology.

Invasive fungal diseases impact on outcome of childhood ALL – an analysis of the international trial AIEOP-BFM ALL 2009

M. Schrappe, S. Izraeli, A. Attarbaschi, 2022, Leukemia.

Initial emergencies in children and adolescents with malignant hematologic–oncological diseases

A. Attarbaschi, G. Mann, 2016, memo - Magazine of European Medical Oncology.

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial

R. Pieters, L. Silverman, M. Schrappe, 2007, The Lancet.

Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.

Ulrich Göbel, M. Schrappe, H. G. Einsiedel, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol

R. Pieters, M. Schrappe, F. Locatelli, 2017, Leukemia.

Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol

F Locatelli, G Mann, R. Pieters, 2016, Leukemia.

Clinical characteristics and treatment outcome of infants with non‐Hodgkin lymphoma

W. Klapper, B. Burkhardt, M. Schrappe, 2007, British journal of haematology.

EARLY AND RELIABLE DIAGNOSIS OF NON-HODGKIN LYMPHOMA in CHILDHOOD AND ADOLESCENCE: Contribution of Cytomorphology and Flow Cytometric Immunophenotyping

O. Haas, B. Meister, A. Attarbaschi, 2006, Pediatric hematology and oncology.

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

J. Harbott, M. Schrappe, G. Henze, 2010, Leukemia.

CNS Involvement in Childhood and Adolescence Non-Hodgkin Lymphoma: Prevalence and Patient’s Outcome Differ According to the Subtype.

B. Burkhardt, M. Schrappe, R. Parwaresch, 2005 .

Extramedullary plasmacytoma of the adenoids

A. Chott, I. Simonitsch, H. Gadner, 2007, Pediatric blood & cancer.

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

Christian Urban, Martin Zimmermann, Martin Stanulla, 2007, Blood.

The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.

B. Burkhardt, M. Schrappe, R. Parwaresch, 2004, Blood.

Analysis of common glucocorticoid response genes in childhood acute lymphoblastic leukemia in vivo identifies cell cycle but not apoptosis genes

R. Crazzolara, R. Kofler, S. Schmidt, 2020, medRxiv.

Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia – a Population-Based Analysis of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group

A. Attarbaschi, U. Pötschger, G. Mann, 2022, Pediatric hematology and oncology.

Outcomes after induction failure in childhood acute lymphoblastic leukemia.

C. Pui, A. Baruchel, L. Silverman, 2012, The New England journal of medicine.

Prognostic relevance of TLX3 (HOX11L2) expression in childhood T‐cell acute lymphoblastic leukaemia treated with Berlin–Frankfurt–Münster (BFM) protocols containing early and late re‐intensification elements

O. Haas, M. Schrappe, A. Attarbaschi, 2010, British journal of haematology.

O. Haas, M. Schrappe, A. Attarbaschi, 2010, British Journal of Haematology.

Mixed Lineage Leukemia–Rearranged Childhood Pro-B and CD10-Negative Pre-B Acute Lymphoblastic Leukemia Constitute a Distinct Clinical Entity

T. Lion, A. Borkhardt, M. König, 2006, Clinical Cancer Research.

Mediastinal mass in childhood T-cell acute lymphoblastic leukemia: significance and therapy response.

M. Schrappe, A. Attarbaschi, H. Gadner, 2002, Medical and pediatric oncology.

TREATMENT OF CHILDHOOD ALL 3123 an increased leukemic cell

W. Hiddemann, M. Schrappe, G. Henze, 2002 .

Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy

J. Whitlock, J. Buechner, G. Mann, 2021, Frontiers in Pediatrics.

Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis

M. König, A. Attarbaschi, O. Haas, 2004, Leukemia.

Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture.

M. Schrappe, G. Mann, L. Löning, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnostic C erebrospinal F luid E xamination i n C hildren W ith Acute L ymphoblastic L eukemia: S ignificance o f L ow L eukocyte Counts W ith B lasts o r T raumatic L umbar P uncture

M. Schrappe, G. Mann, A. Reiter, 2003 .

Philadelphia chromosome‐positive mature B‐cell (Burkitt cell) leukaemia

T. Lion, O. Haas, H. Gadner, 2002, British journal of haematology.

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

Michael N Dworzak, Ulrike Pötschger, D. Printz, 2002, Blood.

Prognostic signiﬁcance and modalities of ﬂow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia minimal in

D. Printz, U. Pötschger, H. Gadner, 2002 .

Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone

R. Crazzolara, P. Ambros, U. Pötschger, 2017, Clinical Cancer Research.

Genomic Analysis of Bone Marrow-Derived Disseminated Neuroblastoma Cells

Ulrike, Martin, P. Ambros, 2016 .

Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7

J. Harbott, S. Fenu, G. Basso, 1999, Leukemia.

Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol

G. Heinze, T. Lion, O. Haas, 1999, European journal of haematology.

Ewing tumor after treatment of Ki-1+ anaplastic large cell lymphoma. Therapy-associated secondary neoplasm or unrelated coincidence?

O. Haas, I. Simonitsch, H. Gadner, 1995, Cancer genetics and cytogenetics.

Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

M. Tiemann, M. Schrappe, A. Chott, 1999, Blood.

Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia

M. König, A. Attarbaschi, O. Haas, 2009, Leukemia.

Expression of Tumour Necrosis Factor (TNF)-related Apoptosis-Inducing Ligand (TRAIL) Receptors and Sensitivity to TRAIL-induced Apoptosis in Primary B-cell Acute Lymphoblastic Leukaemia Cells

U. Jaeger, A. Younes, H. Gadner, 2000 .

KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia

O. Haas, M. Schrappe, F. Locatelli, 2015, Leukemia.

CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia

E. Froňková, M. Morak, M. Zeginigg, 2012, Leukemia.

ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling.

A. Hall, J. Harbott, O. Haas, 2011, Blood.

Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.

O. Haas, M. Schrappe, A. Waage, 1995 .

Minimal residual disease analysis in children with t ( 12 ; 21 )-positive acute lymphoblastic leukemia : comparison of Ig / TCR rearrangements

O. Haas, M. Schrappe, H. Gadner, 2006 .

Trial NHL-BFM 90 Intensification of Therapy: A Report of the Berlin-Frankfurt-Münster Group Improved Treatment Results in Childhood B-Cell Neoplasms With Tailored

M. Tiemann, M. Schrappe, A. Chott, 2013 .

Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

J. Harbott, O. Haas, G. Basso, 1997, Blood.

Chromosome 14 copy number-dependent IGH gene rearrangement patterns in high hyperdiploid childhood B-cell precursor ALL: implications for leukemia biology and minimal residual disease analysis

M. König, O. Haas, J. Dongen, 2009, Leukemia.

Immunogenotype Changes Prevail in Relapses of Young Children with TEL-AML1-Positive Acute Lymphoblastic Leukemia and Derive Mainly from Clonal Selection

J. V. van Dongen, V. V. D. van der Velden, J. Harbott, 2005, Clinical Cancer Research.

Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).

B. Schäfer, M. Schrappe, C. Bartram, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1

O. Haas, U. Kaindl, J. Neil, 2010, Oncogene.

Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols

D. Steinemann, T. Révész, O. Haas, 2019, Haematologica.

Expression of tumour necrosis factor (TNF)‐related apoptosis‐inducing ligand (TRAIL) receptors and sensitivity to TRAIL‐induced apoptosis in primary B‐cell acute lymphoblastic leukaemia cells

U. Jaeger, A. Younes, H. Gadner, 2000, British journal of haematology.

AIEOP‐BFM Consensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic Leukemia

Barbara Buldini, Giuseppe Basso, Richard Ratei, 2018, Cytometry. Part B, Clinical cytometry.

Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia

B. Wood, M. Schrappe, C. Bartram, 2018, JNCI cancer spectrum.

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.

J. Harbott, M. Schrappe, C. Bartram, 2016, Blood.

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol

M. D. Boer, R. Pieters, M. Schrappe, 2009, Leukemia.

History of Diagnoses and Treatment Strategies in Pediatric Non-Hodgkin’s Lymphomas

G. Mann, 2019, Non-Hodgkin's Lymphoma in Childhood and Adolescence.

Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.

J. Harbott, H. Gadner, G. Mann, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence of Secondary Leukemias After Therapy of Childhood Hodgkin’s Disease Without Nitrogen-Mustard. Results of the German-Austrian Study Group

J. Harbott, H. Gadner, G. Mann, 1997 .

Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90.

M. Tiemann, W. Ludwig, G. Mann, 2000, Medical and pediatric oncology.

The role of surgery in the treatment of pediatric B-cell non-Hodgkin's lymphoma.

A. Attarbaschi, H. Gadner, G. Mann, 2002, Journal of pediatric surgery.

Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome

M. Schrappe, G. Henze, A. Kulozik, 2013, British Journal of Haematology.

Second malignancies after treatment of childhood non-Hodgkin lymphoma – a report of the Berlin-Frankfurt-Muenster study group

W. Klapper, B. Burkhardt, M. Schrappe, 2020, Haematologica.

Study )rearranged acute lymphoblastic leukemia: results from the Interfant-99 MLL ( mixed-lineage-leukemia poor prognostic subgroup of infants with Improved outcome with hematopoietic stem cell transplantation in a

R. Pieters, L. Silverman, M. Schrappe, 2010 .

Implications of delayed bone marrow aspirations at the end of treatment induction for risk stratification and outcome in children with acute lymphoblastic leukaemia

E. Froňková, M. Schrappe, C. Bartram, 2016, British journal of haematology.

Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study.

W. Klapper, B. Burkhardt, A. Attarbaschi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Limited stage I disease is not necessarily indicative of an excellent prognosis in childhood anaplastic large cell lymphoma.

A. Attarbaschi, K. Horibe, A. Uyttebroeck, 2011, Blood.

Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.

B. Burkhardt, M. Schrappe, W. Ludwig, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of age and gender on biology, clinical features and treatment outcome of non‐Hodgkin lymphoma in childhood and adolescence

B. Burkhardt, M. Schrappe, R. Parwaresch, 2005, British journal of haematology.

Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.

M. Tiemann, M. Schrappe, R. Parwaresch, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

M. Tiemann, M. Schrappe, R. Parwaresch, 2001, Blood.

Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.

M. Tiemann, M. Schrappe, R. Parwaresch, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group

N. Heerema, J. Harbott, O. Haas, 2000, Leukemia.

Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.

W. Klapper, B. Burkhardt, M. Schrappe, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development of treatment and clinical results in childhood AML in Austria (1993–2013)

T. Lion, O. Haas, B. Meister, 2014, memo - Magazine of European Medical Oncology.

High hyperdiploid acute lymphoblastic leukemia (ALL)—A 25‐year population‐based survey of the Austrian ALL‐BFM (Berlin‐Frankfurt‐Münster) Study Group

M. König, O. Haas, B. Meister, 2017, Pediatric blood & cancer.

Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia

A. Schulz, T. Lion, M. Schrappe, 2016, Haematologica.

Dexamethasone in Induction Can Eliminate One Third of All Relapses in Childhood Acute Lymphoblastic Leukemia (ALL): Results of An International Randomized Trial in 3655 Patients (Trial AIEOP-BFM ALL 2000)

M. Schrappe, C. Bartram, M. Valsecchi, 2008 .

Long‐term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria – A population‐based report of the Austrian Berlin‐Frankfurt‐Münster (BFM) Study Group

O. Haas, B. Meister, G. Henze, 2009, British journal of haematology.

A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.

R. Hawliczek, P. Höcker, H. Gadner, 1997, Klinische Padiatrie.

Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation

T. Lion, C. Peters, G. Mann, 2012, Leukemia.

Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.

R. Pötter, H. Holte, K. Schmiegelow, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL‐BFM treatment protocols

M. Schrappe, G. Hempel, G. Fleischhack, 1999, British journal of haematology.

Distinct fluctuations of ammonia levels during asparaginase therapy for childhood acute leukemia

A. Attarbaschi, O. Haas, H. Gadner, 2007, Pediatric blood & cancer.

High-dose cyclophosphamide, adriamycin, and vincristine (HD-CAV) in children with recurrent solid tumor.

H. Gadner, G. Mann, G. Mostbeck, 1994, Pediatric hematology and oncology.

Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group.

R. Pötter, D. Körholz, A. Claviez, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparative phenotype mapping of normal vs. malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations.

D. Printz, H. Gadner, G. Mann, 1998, Experimental hematology.

Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Long Term Results of the International ALCL99 Trial

W. Klapper, B. Burkhardt, S. Turner, 2020, Cancers.

Expression, regulation and function of phosphofructo-kinase/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells

R. Kofler, S. Schmidt, J. Rainer, 2010, BMC Cancer.

High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia

G Mann, R. Möhle, R. Crazzolara, 2001, British journal of haematology.

Childhood Acute Nonlymphoblastic Leukemia — Results of the Austrian-Hungarian Acute Myeloid Leukemia Studies IGCI-84 and 90

H. Gadner, C. Urban, G. Mann, 1997 .

CD20 up-Regulation in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia during Induction Treatment Translates into Higher Rituximab-Sensitivity.

O. Haas, A. Attarbaschi, H. Gadner, 2008 .

Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma.

W. Klapper, I. Salaverria, B. Burkhardt, 2023, The Lancet. Haematology.

Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.

Arndt Borkhardt, Christina Peters, A. Borkhardt, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of Infants Less Than One Year of Age with Acute Lymphoblastic Leukemia Treated with the Interfant-99 Protocol.

R. Pieters, M. Schrappe, J. Starý, 2006 .

High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.

R. Pötter, D. Körholz, G. Mann, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994-2011.

H. Karim-Kos, I. Slavc, C. Urban, 2016, Cancer epidemiology.

Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial

M. Schrappe, M. Kuhlen, M. Valsecchi, 2019, Leukemia.

Characteristics, management, and outcome of pediatric patients with post‐transplant lymphoproliferative disease—A 20 years' experience from Austria

R. Crazzolara, A. Attarbaschi, I. Michel-Behnke, 2021, Cancer reports.

PD‐L1 and PD1 expression in post‐transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter‐ and intra‐individual descriptive study covering the whole spectrum of PTLD categories

A. Attarbaschi, C. Hutter, I. Michel-Behnke, 2019, Cancer medicine.

CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia

N. Popitsch, E. Mejstrikova, O. Hrusak, 2019, Haematologica.

Cytochemically Myeloperoxidase Positive Childhood Acute Leukemia With Lymphoblastic Morphology Treated as Lymphoblastic Leukemia

O. Haas, W. Pickl, A. Attarbaschi, 2010, Journal of pediatric hematology/oncology.

Clinical and Immunological Correction of DOCK8 Deficiency by Allogeneic Hematopoietic Stem Cell Transplantation Following a Reduced Toxicity Conditioning Regimen

C. Peters, G. Mann, B. Belohradsky, 2012, Pediatric hematology and oncology.

INTERNATIONAL COLLABORATIVE TREATMENT PROTOCOL FOR INFANTS UNDER ONE YEAR WITH ACUTE LYMPHOBLASTIC OR BIPHENOTYPIC LEUKEMIA

R. Pieters, L. Silverman, M. Schrappe, 2015 .

C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease.

A. Berghold, G. Mann, C. Urban, 2003, Medical and pediatric oncology.

Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a “watch and wait” strategy after complete resection

B. Burkhardt, A. Attarbaschi, A. Uyttebroeck, 2013, Annals of Hematology.

A novel type of MLL/AF10 fusion transcript in a child with acute megakaryocytic leukemia (AML-M7)

A. Borkhardt, O. Haas, F. Lampert, 1995, Leukemia.

Concurrent Acute Myelofibrosis and Acute Lymphoblastic Leukemia in Childhood: Case Report and Review of the Literature.

O. Haas, R. Panzer‐Grümayer, G. Mann, 2018, Journal of pediatric hematology/oncology.

Other (Non-CNS/Testicular) Extramedullary Localizations of Childhood Relapsed Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma—A Report from the ALL-REZ Study Group

B. Burkhardt, C. Eckert, G. Henze, 2021, Journal of Clinical Medicine.

Minimal Residual Disease–based Treatment is Adequate for Relapse-prone Childhood Acute Lymphoblastic Leukemia with an intrachromosomal amplification of chromosome 21: The experience of the ALL-BFM 2000 trial

A. Teigler‐Schlegel, M. König, J. Harbott, 2014, Klinische Pädiatrie.

Reduced Intensity Delayed Intensification in Standard-Risk Patients Defined By Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia: Results of an International Randomized Trial in 1164 Patients (Trial AIEOP-BFM ALL 2000)

M. Schrappe, C. Bartram, M. Valsecchi, 2016 .

Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction

B. Burkhardt, M. Schrappe, M. Valsecchi, 2023, HemaSphere.

Fresh frozen plasma contains free asparagine and may replace the plasma asparagine pool during L-asparaginase therapy

A. Attarbaschi, O. Haas, H. Gadner, 2008, Leukemia.

The impact of central review and central therapy planning on the treatment of children and adolescents with Hodgkin lymphoma.

J. Haerting, A. Claviez, G. Mann, 2014, European journal of cancer.

Rothia mucilaginosa bacteremia: A 10‐year experience of a pediatric tertiary care cancer center

A. Attarbaschi, C. Hutter, A. Indra, 2019, Pediatric blood & cancer.

Treatment of Childhood Acute Nonlymphoblastic Leukemia — Final Results of the Austrian-Hungarian Study AML-IGCL-84

H. Gadner, C. Urban, G. Mann, 1996 .

Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment

A. Borkhardt, C. Eckert, G. Henze, 2015, Leukemia.

Incidence of Hypersensitivity Reactions (HSR) Reactions (HSR) to Peg-Asparaginase (PEG-ASP) in 6136 Patients Treated in the AIEOP-BFM ALL 2009 Study Protocol

M. Zucchetti, M. Schrappe, M. Valsecchi, 2019, Blood.

Chronic myelomonocytic leukemia (CMML) in childhood

O. Haas, S. Fenu, G. Basso, 1994 .

Management of children and adolescents with gray zone lymphoma: A case series

A. Attarbaschi, G. Mann, M. Dworzak, 2020, Pediatric blood & cancer.

Clinical significance of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia

A. Attarbaschi, G. Mann, M. Steiner, 2007, Leukemia & lymphoma.

Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years' experience.

A. Attarbaschi, K. Dieckmann, H. Gadner, 2002, Wiener klinische Wochenschrift.

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol

M. D. Boer, R. Pieters, M. Schrappe, 2009 .

Clinical Trials and Observations

L. Silverman, M. Schrappe, A. Attarbaschi, 2022 .

Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: comparison of Ig/TCR rearrangements and the genomic fusion gene.

O. Haas, M. Schrappe, H. Gadner, 2006, Haematologica.

Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.

D. Hasenclever, A. Attarbaschi, T. Leblanc, 2023, The Lancet. Oncology.

Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.

A. Attarbaschi, H. Gadner, C. Urban, 2002, Wiener klinische Wochenschrift.

Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials.

G. Henze, G. Mann, A. Reiter, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia : Long-term results of the AIEOP-BFM ALL 2000 trial in Austria.

T. Lion, O. Haas, B. Meister, 2023, Wiener klinische Wochenschrift.

MRD levels during the first months of treatment indicate relapses in children with t(12;21)-positive ALL

M. König, O. Haas, H. Gadner, 2000, Leukemia.

Acute monocytic leukaemia originating from MLL‐MLLT3‐positive pre‐B cells

M. König, O. Haas, R. Marschalek, 2010, British journal of haematology.

Targeted mutation screening of 292 candidate genes in 38 children with inborn haematological cytopenias efficiently identifies novel disease‐causing mutations

O. Haas, C. Bock, W. Holter, 2018, British journal of haematology.

childhood ALL harboring clones as main relapse-driving force in - P2RY8-CRLF2 role of Small sizes and indolent evolutionary dynamics challenge the potential

O. Haas, M. Morak, A. Attarbaschi, 2013 .

Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.

O. Haas, P. Ambros, P. Höcker, 1992, Bone marrow transplantation.

No Influence on the Incidence of Osteonecroses When Dexamethasone Replaces Prednisone during Induction Treatment for Childhood ALL: Results of Trial ALL-BFM 2000.

M. Schrappe, A. Möricke, M. Frühwald, 2008 .

Asparagine and aspartic acid concentrations in bone marrow versus peripheral blood during Berlin–Frankfurt–Münster-based induction therapy for childhood acute lymphoblastic leukemia

O. Haas, A. Attarbaschi, U. Pötschger, 2012, Leukemia and Lymphoma.

Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia.

M. Schrappe, M. Valsecchi, S. Izraeli, 2023, Haematologica.

ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling.

R. Arceci, A. Hall, J. Harbott, 2011, Blood.

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

D. Printz, U. Pötschger, H. Gadner, 2002, Blood.

Fractionated Total Body Irradiation or Busulfan in Combination with Etoposide and Cyclophosphamide as Conditioning Regimen for Bone Marrow Transplantation in Acute Leukemias in Children

P. Höcker, H. Gadner, G. Mann, 1994 .

Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.

C. Pui, N. Heerema, C. Mullighan, 2014, Blood.

Acute Lymphoblastic Leukemia in Children with Down Syndrome: A Report From the Ponte Di Legno Study Group

C. Pui, R. Pieters, N. Heerema, 2011 .

Costs and cost-effectiveness of allogeneic stem cell transplantation in children are predictable.

A. Attarbaschi, T. Klingebiel, U. Pötschger, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.